Unlock a Hoover's Basic Subscription. To talk to a Business Information Consultant please call (866) 473-3932
Pharmasset, Inc. Company Profile
Pharmasset hoped its drugs would go viral on the commercial market. Prior to its acquisition by Gilead Sciences, the clinical-stage pharmaceutical company was developing a class of compounds known as nucleoside/tide analogs as oral drug candidates to treat viral infections. It had a number of candidates in development to treat chronic hepatitis C virus (HCV) infection, a leading cause of liver disease, both in clinical development and preclinical research stages; one such candidate was being developed in collaboration with Roche.
Hoover’s Inc., a D&B Company puts you on the fastest path to business. Hoover's offers proprietary business information through the Internet, data feeds, wireless devices, and co-branding agreements with other online services.